CHRONIC HYPOPARATHYROIDISM

Clinical trials for CHRONIC HYPOPARATHYROIDISM explained in plain language.

Never miss a new study

Get alerted when new CHRONIC HYPOPARATHYROIDISM trials appear

Sign up with your email to follow new studies for CHRONIC HYPOPARATHYROIDISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

New hormone therapy shows promise for rare calcium disorder

Disease control Completed

This early-stage study tested a new hormone drug called AZP-3601 in healthy volunteers and people with chronic hypoparathyroidism, a condition where the body doesn't produce enough parathyroid hormone. Researchers wanted to understand the drug's safety, how it moves through the b…

Matched conditions: CHRONIC HYPOPARATHYROIDISM

Phase: PHASE1, PHASE2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

CHRONIC HYPOPARATHYROIDISM

Get alerted when new CHRONIC HYPOPARATHYROIDISM trials appear

New hormone therapy shows promise for rare calcium disorder